Announcement

October 13, 2022

Otium is developing a Software as a Service product named Regulatory DocWriter, an online document writing platform, which automates the regulatory writing component for Investigator Brochures (IBs), Clinical Study Reports (CSRs), Clinical Study protocols, Informed Consent, Trial Disclosure Forms, and similar documents. The generation of these standard documents is one of the most time-consuming stages in the development, testing and approval of new drugs, taking weeks and in some cases months to complete.